{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:19:40Z","timestamp":1775002780366,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":18,"publisher":"Springer US","isbn-type":[{"value":"9781071652176","type":"print"},{"value":"9781071652183","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5218-3_21","type":"book-chapter","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:24:10Z","timestamp":1774999450000},"page":"295-305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treating Immune Thrombotic\u00a0Thrombocytopenic Purpura with Immunosuppressive Agents"],"prefix":"10.1007","author":[{"given":"Konstantine","family":"Halkidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"22","key":"21_CR1","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","volume":"339","author":"HM Tsai","year":"1998","unstructured":"Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585\u20131594","journal-title":"N Engl J Med"},{"issue":"12","key":"21_CR2","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1182\/blood-2003-12-4165","volume":"103","author":"C Klaus","year":"2004","unstructured":"Klaus C, Plaimauer B, Studt JD, Dorner F, Lammle B, Mannucci PM, Scheiflinger F (2004) Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura. Blood 103:4514\u20134519","journal-title":"Blood"},{"key":"21_CR3","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","volume":"3","author":"JA Kremer Hovinga","year":"2017","unstructured":"Kremer Hovinga JA, Coppo P, L\u00e4mmle B, Moake JL, Miyata T, Vanhoorelbeke K (2017) Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers 3:17020","journal-title":"Nat Rev Dis Primers"},{"key":"21_CR4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/jth.15176","volume":"19","author":"J Sui","year":"2021","unstructured":"Sui J, Lu R, Halkidis K, Kocher NK, Cao W, Marques MB, Zheng XL (2021) Plasma levels of S100A8\/A9, histone\/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura. J Thromb Haemost 19:370\u2013379","journal-title":"J Thromb Haemost"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1182\/blood.2022016640","volume":"140","author":"S Chaturvedi","year":"2022","unstructured":"Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Baumann Kreuziger L, Sadler JE, Sridharan M, Go RS, McCrae KR, Upreti HV, Liu A, Lim MY, Gangaraju R, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson A, Davis E, Evans MD, Mazepa MA, United States Thrombotic Microangiopathies C (2022) Race, rituximab, and relapse in TTP. Blood 140:1335\u20131344","journal-title":"Blood"},{"key":"21_CR6","first-page":"283","volume":"17","author":"D Kohn","year":"1981","unstructured":"Kohn D, Herman J, Flatau E, Daher O, Lev A, Dubnov B (1981) Thrombotic thrombocytopenic purpura with a subacute course: remission after steroids and high-dose plasma exchange. Isr J Med Sci 17:283\u2013285","journal-title":"Isr J Med Sci"},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2141.1994.tb04915.x","volume":"87","author":"N Novitzky","year":"1994","unstructured":"Novitzky N, Jacobs P, Rosenstrauch W (1994) The treatment of thrombotic thrombocytopenic purpura: plasma infusion or exchange? Br J Haematol 87:317\u2013320","journal-title":"Br J Haematol"},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.transci.2006.05.020","volume":"36","author":"F Ozkalemkas","year":"2007","unstructured":"Ozkalemkas F, Ali R, Ozkocaman V, Ozcelik T, Ozkan A, Tunali A (2007) Therapeutic plasma exchange plus corticosteroid for the treatment of the thrombotic thrombocytopenic purpura: a single institutional experience in the southern Marmara region of Turkey. Transfus Apher Sci 36:109\u2013115","journal-title":"Transfus Apher Sci"},{"key":"21_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jemermed.2012.01.027","volume":"43","author":"CS Kessler","year":"2012","unstructured":"Kessler CS, Khan BA, Lai-Miller K (2012) Thrombotic thrombocytopenic purpura: a hematological emergency. J Emerg Med 43:538\u2013544","journal-title":"J Emerg Med"},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00000441-197901000-00009","volume":"277","author":"J Peterson","year":"1979","unstructured":"Peterson J, Amare M, Henry JE, Bone RC (1979) Splenectomy and antiplatelet agents in thrombotic thrombocytopenic purpura. Am J Med Sci 277:75\u201389","journal-title":"Am J Med Sci"},{"key":"21_CR11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1182\/bloodadvances.2017008268","volume":"1","author":"JP Westwood","year":"2017","unstructured":"Westwood JP, Thomas M, Alwan F, McDonald V, Benjamin S, Lester WA, Lowe GC, Dutt T, Hill QA, Scully M (2017) Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens. Blood Adv 1:1159\u20131166","journal-title":"Blood Adv"},{"key":"21_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1600-0609.2007.00832.x","volume":"78","author":"HN Ahmad","year":"2007","unstructured":"Ahmad HN, Thomas-Dewing RR, Hunt BJ (2007) Mycophenolate mofetil in a case of relapsed, refractory thrombotic thrombocytopenic purpura. Eur J Haematol 78:449\u2013452","journal-title":"Eur J Haematol"},{"key":"21_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1365-2141.2007.06819.x","volume":"139","author":"SR Cataland","year":"2007","unstructured":"Cataland SR, Jin M, Lin S, Kennedy MS, Kraut EH, George JN, Wu HM (2007) Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity. Br J Haematol 139:486\u2013493","journal-title":"Br J Haematol"},{"key":"21_CR14","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1111\/bjh.19752","volume":"205","author":"J Weisinger","year":"2024","unstructured":"Weisinger J, Bouzid R, Ranta D, Woaye-Hune P, Cohen-Aubart F, Gaible C, Marjanovic Z, Corre E, Joly AC, Baylatry MT, Joly BS, Veyradier A, Coppo P (2024) Efficacy and safety of daratumumab in multiresistant immune-mediated thrombotic thrombocytopenic purpura. Br J Haematol 205:1951\u20131958","journal-title":"Br J Haematol"},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1056\/NEJMc1213206","volume":"368","author":"J Shortt","year":"2013","unstructured":"Shortt J, Oh DH, Opat SS (2013) ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura. N Engl J Med 368:90\u201392","journal-title":"N Engl J Med"},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1111\/j.1537-2995.2012.03578.x","volume":"52","author":"F Beloncle","year":"2012","unstructured":"Beloncle F, Buffet M, Coindre JP, Munoz-Bongrand N, Malot S, Pene F, Mira JP, Galicier L, Guidet B, Baudel JL, Subra JF, Tanguy-Schmidt A, Pourrat J, Azoulay E, Veyradier A, Coppo P, Thrombotic Microangiopathies Reference C (2012) Splenectomy and\/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience. Transfusion 52:2436\u20132444","journal-title":"Transfusion"},{"key":"21_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/BF01957008","volume":"153","author":"S Van Gool","year":"1994","unstructured":"Van Gool S, Brock P, Van Laer P, Van Damme-Lombaerts R, Proesmans W, Casteels-Van Daele M (1994) Successful treatment of recurrent thrombotic thrombocytopenic purpura with plasmapheresis and vincristine. Eur J Pediatr 153:517\u2013519","journal-title":"Eur J Pediatr"},{"key":"21_CR18","first-page":"1182","volume":"10","author":"Z Iqbal","year":"2021","unstructured":"Iqbal Z, Absar M, Akhtar T, Aleem A, Jameel A, Basit S, Ullah A, Afzal S, Ramzan K, Rasool M, Karim S, Mirza Z, Iqbal M, AlMajed M, AlShehab B, AlMukhaylid S, AlMutairi N, Al-Anazi N, Sabar MF, Arshad M, Asif M, Shammas M, Mahmood A (2021) Integrated genomic analysis identifies ANKRD36 gene as a novel and common biomarker of disease progression in chronic myeloid leukemia. Biology (Basel) 10:1182","journal-title":"Biology (Basel)"}],"container-title":["Methods in Molecular Biology","ADAMTS Proteases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5218-3_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:24:11Z","timestamp":1774999451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5218-3_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071652176","9781071652183"],"references-count":18,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5218-3_21","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}